InvestorsHub Logo
Followers 2
Posts 164
Boards Moderated 0
Alias Born 01/26/2010

Re: None

Wednesday, 01/15/2014 5:23:10 PM

Wednesday, January 15, 2014 5:23:10 PM

Post# of 64394





FDA Painkiller Restrictions could boost NYLOXIN - Coverage Initiated on NPHC

http://www.huffingtonpost.com/2013/10/24/fda-hydrocodone-painkillers-access_n_4159316.html

WASHINGTON, - The U.S. Food and Drug Administration recommended tighter restrictions on products that contain hydrocodone, an opioid painkiller present in commonly prescribed, potentially addictive drugs such as Vicodin.

Nyloxin is a non addictive option to opiate based painkillers. It is posed to take advantage of the new restrictions. Marketing Nyloxin as a non addictive painkiller at the same time the FDA restricts opiate based painkiilers could be very beneficial to NPHC shareholders We may see increased interest in the security NPHC.